MONTREAL, April 05, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (the “Corporation” or “LGC”) (LG.V) (LGGCF) announces that it has granted stock options to purchase a total of 6,100,000 common shares of the Corporation to certain new executive officers. All of these options are exercisable at a price of $0.13 per share and have a term of five years. The options are subject in all respects to the terms of LGC’s stock option plan, the requirements of the TSX Venture Exchange and shareholder approval.
About LGC Capital
LGC is a leading cannabis investment firm with a focus on the Legal Global Cannabis market. Through its growing portfolio investment companies, LGC is building a vertically integrated system of interconnected legal cannabis companies with cultivation, processing and distribution in Australia, Jamaica, Switzerland, Italy, and Canada serving domestic and export markets. LGC is a Canadian incorporated public company listed on the TSX Venture Exchange.
Through its partners and assuming pending transactions under review by the TSXV are approved, LGC presently will have interests in over 450,000 square feet of planted cannabis in Jamaica, Switzerland, Italy, and Australia. That is expected to increase to over 2,100,000 square feet by 2021, as its portfolio companies execute their expansion plans, in addition to the anticipated licensing of Tricho-Med’s operations in Quebec, Canada.
LGC partners currently sell cannabis products in over 1,000 points of sale across Switzerland and Italy under the ONE Premium Cannabis and EasyJoint brands as well as medical cannabis oils in Australia under the Little Green Pharma brand. LGC’s partners’ branded products are available in a variety of formats including dry cannabis flower, tinctures, oils, seeds, and beverages.
For further information please contact:
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.